Morgan Stanley
COCHW icon

Morgan Stanley’s Envoy Medical Warrant COCHW Stock Holding History

Morgan Stanley’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-933
Closed -$36 – 8333
2025
Q4 		$36 Hold
933
– – ﹤0.01% 7960
2025
Q3 		$35 Hold
933
– – ﹤0.01% 7946
2025
Q2 		$33 Hold
933
– – ﹤0.01% 7897
2025
Q1 		$31 Hold
933
– – ﹤0.01% 7863
2024
Q4 		$44 Hold
933
– – ﹤0.01% 7654
2024
Q3 		$61 Hold
933
– – ﹤0.01% 7522
2024
Q2 		$47 Hold
933
– – ﹤0.01% 7515
2024
Q1 		$99 Sell
933
-933
-50% -$63 ﹤0.01% 7377
2023
Q4 		$38 Buy
+1,866
New +$50 ﹤0.01% 7704

Other funds holding COCHW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Morgan Stanley's COCHW Position: Q1 2026 in Review

Morgan Stanley sold out of Envoy Medical Warrant (COCHW) in Q1 2026, closing a stake of 933 shares — an estimated $36 sold.

Morgan Stanley first reported a position in COCHW in Q4 2023 and held it in 9 quarters. The position peaked at $99 in Q1 2024. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Morgan Stanley reported no remaining Envoy Medical Warrant position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 933 Envoy Medical Warrant shares in Q1 2026, an estimated $36.
  • Morgan Stanley first reported a position in Envoy Medical Warrant in Q4 2023 and held it in 9 quarters.
  • Morgan Stanley's Envoy Medical Warrant position peaked at $99 in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.